Anzeige
Mehr »
Freitag, 11.07.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
307 Leser
Artikel bewerten:
(1)

ConvaTec Launches Foam Lite' ConvaTec Dressing, Expanding Its Foam Portfolio for a Wide Variety of Wounds

- Light, flexible foam dressing developed for low to non-exuding chronic and acute wounds

- Complements ConvaTec's AQUACEL® Foam dressings, providing customers with range of advanced foam dressings to suit everyday needs and help patients resume their daily lives

FLORENCE, Italy, Sept. 27,2016 /PRNewswire/ --ConvaTec, a leading global medical technology company, today announced the launch of Foam Lite' ConvaTec dressing, expanding the company's portfolio of silicone foam dressings and providing customers with a broad range of advanced dressings for the management of a wide variety of chronic and acute wounds.

ConvaTec is showcasing the new foam dressing, alongside its advanced wound care products including the new Avelle' disposable negative pressure wound therapy system, to wound specialists attending the 5th Conference of the World Union of Wound Healing Societies (WUWHS) from 25-29 September in Florence, Italy.

Foam Lite' ConvaTec dressing is a thin, flexible foam dressing developed specifically for managing low to non-exuding wounds, such as skin abrasions, skin tears and partial thickness burns, which do not require the absorbency of regular foam dressings. The new dressing complements ConvaTec's range of AQUACEL® Foam dressings for moderately exuding wounds.

"Wound specialists today rely on advanced foam dressings for managing a wide variety of patients' wounds - from low to non-exuding superficial wounds to those that are moderately exuding and thus require more absorption," said Fiona Adam, Vice President and General Manager, Advanced Wound Care.

"Foam Lite' ConvaTec dressing was developed, alongside our successful line of AQUACEL® Foam dressings, to help our customers address the challenges of wound care that they see every day -- protecting fragile skin, defending against infection and nurturing with a moist wound healing environment - and to help their patients resume their daily lives."

"In my practice, as a Plastic Surgeon, my experience is that the new Foam Lite' ConvaTec dressing is easy to apply, especially in the areas of skin folds," said Dr Joseph Chateau, Department of Plastic, Reconstructive & Aesthetic Surgery, Lyon Hospital University Center (HCL), in Lyon, France. "Patients' tolerance is excellent when removing the dressing, and the adhesive is gentle to the skin."

Foam Lite' ConvaTec dressing is a thin foam dressing with a breathable film and perforated, gentle silicone adhesive.* The new dressing is flexible and conforms* to the body even in awkward positions or places such as elbows, wrists, knees and ankles.

The skin-friendly silicone adhesive is easy to apply, re-position and remove; it will not stick to gloves or to itself, and is designed to be non-damaging (atraumatic) to the wound and periwound skin upon dressing removal.* The soft foam layer is designed to absorb low levels of exudate and help maintain a moist wound healing environment.* The soft-to-touch outer film provides a protective barrier against water, bacteria and viruses.*

Foam Lite' ConvaTec dressing received CE mark approval and is available in France, Germany, the U.K., Canada, Australia and New Zealand, and will soon be available in additional European markets. The new dressing is available in a number of sizes, which can also be cut to shape, and has a maximum recommended wear time of 7 days.

For more information about Foam Lite' ConvaTec dressing and the company's full range of advanced wound dressings, visit www.convatec.co.uk or call ConvaTec customer service.

About ConvaTec
ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. The company is owned by Nordic Capital and Avista Capital Partners.

*As demonstrated in vitro

Foam Lite and AQUACEL are trademarks of ConvaTec Inc.

© 2016 ConvaTec Inc.

AP-016924-MM

References available on request

Contact:

Punnie Donohue
ConvaTec
punnie.donohue@convatec.com




© 2016 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.